• 1197 Citations
  • 18 h-Index
20002019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Li-Yuan Bai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Autophagy Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Cells Chemical Compounds
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Taiwan Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 1197 Citations
  • 18 h-Index
  • 67 Article
  • 6 Letter
  • 1 Review article

Divaricoside Exerts Antitumor Effects, in Part, by Modulating Mcl-1 in Human Oral Squamous Cell Carcinoma Cells

Weng, J. R., Bai, L-Y., Chiu, S. J., Chiu, C-F., Lin, W. Y., Hu, J. L. & Shieh, T. M., Jan 1 2019, In : Computational and Structural Biotechnology Journal. 17, p. 151-159 9 p.

Research output: Contribution to journalArticle

Open Access
Glycosides
Squamous Cell Carcinoma
Cardiac Glycosides
Cells
Cell death

Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial

Yoshikawa, T., Muro, K., Shitara, K., Oh, D. Y., Kang, Y. K., Chung, H. C., Kudo, T., Chin, K., Kadowaki, S., Hamamoto, Y., Hironaka, S., Yoshida, K., Yen, C. J., Omuro, Y., Bai, L. Y., Maeda, K., Ozeki, A., Yoshikawa, R. & Kitagawa, Y., Aug 2 2019, In : JAMA Network Open. 2, 8, p. e198243

Research output: Contribution to journalArticle

Open Access
oxaliplatin
Far East
Paclitaxel
Stomach Neoplasms
Randomized Controlled Trials

Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer

Satoh, T., Kang, Y. K., Chao, Y., Ryu, M. H., Kato, K., Cheol Chung, H., Chen, J. S., Muro, K., Ki Kang, W., Yeh, K. H., Yoshikawa, T., Oh, S. C., Bai, L-Y., Tamura, T., Lee, K. W., Hamamoto, Y., Kim, J. G., Chin, K., Oh, D. Y., Minashi, K. & 5 others, Cho, J. Y., Tsuda, M., Tanimoto, M., Chen, L. T. & Boku, N., Jan 1 2019, In : Gastric Cancer.

Research output: Contribution to journalArticle

Open Access
Esophagogastric Junction
Phase III Clinical Trials
Stomach
Randomized Controlled Trials
Safety

Treatment of pembrolizumab-induced cutaneous lesions with ruxolitinib

Chen, C. Y., Chiu, C-F. & Bai, L-Y., May 1 2019, In : European Journal of Cancer. 113, p. 69-71 3 p.

Research output: Contribution to journalLetter

Skin
pembrolizumab
INCB018424
1 Citation (Scopus)

Ursolic acid induces apoptosis and autophagy in oral cancer cells

Lin, C. W., Chin, H. K., Lee, S. L., Chiu, C-F., Chung, J-G., Lin, Z. Y., Wu, C. Y., Liu, Y. C., Hsiao, Y. T., Feng, C. H., Bai, L-Y. & Weng, J. R., Jan 1 2019, In : Environmental Toxicology. 34, 9, p. 983-991 9 p.

Research output: Contribution to journalArticle

Mouth Neoplasms
Autophagy
apoptosis
cancer
Cells